AbbVie
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
ABBV News
AbbVie ( ) First Quarter 2024 Results Key Financial Results Revenue: US$12.3b (flat on 1Q 2023). Net income: US$1.37b (up by US$1.14b from 1Q 2023). Profit...
Shares of AbbVie (NYSE:ABBV) sank on Friday after the pharmaceutical company reported first-quarter results. Despite beating earnings estimates ($2.31 per share...
Pharmaceutical giant AbbVie Inc. (ABBV) shares came under pressure as the market closed on Friday, following the disappointing first quarter sales performance o...
Analyst ratings
57%
of 30 ratingsMore ABBV News
Shares of AbbVie (NYSE:ABBV) were down 6% in afternoon trading Friday in the wake of the drugmaker's Q1 earnings report and news that Cigna (CI) plans to offer...
AbbVie Inc. ABBV reported adjusted earnings of $2.31 per share for first-quarter 2024, beating the Zacks Consensus Estimate of $2.26. The reported earnings also...
vzphotos Article Thesis AbbVie Inc. (NYSE:ABBV) reported its first quarter earnings results Friday morning. The company's results beat estimates on both lines...
Jim Cramer's daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. Chevron : The oil giant beat on quarterly earnings but miss...
AbbVie raised its full year profit guidance today, even as sales of its flagship medication have continued to fall. Are self-driving cars safe enough yet? CC S...
Loading... Loading... Friday, AbbVie Inc ABBV reported first-quarter adjusted EPS of $2.31, down 6.1% Y/Y, beating the consensus of $2.23. Net revenues reache...
AbbVie (ABBV) stock was muted early Friday after the pharma giant reported adjusted earnings of $2.31 per share and $12.31 billion in first-quarter sales. X O...
